Tetrazole thioacetanilides: Potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant
Authors:
- Ester MuragliaEMEster Muraglia
- Olaf D. KinzelOKOlaf D. Kinzel
- Ralph LauferRLRalph Laufer
- Michael D. MillerMMMichael D. Miller
- Gregory MoyerGMGregory Moyer
- Vandna MunshiVMVandna Munshi
- Federica OrvietoFOFederica Orvieto
- Maria Cecilia PalumbiMPMaria Cecilia Palumbi
- Giovanna PescatoreGPGiovanna Pescatore
- Michael RowleyMRMichael Rowley
- Peter D. WilliamsPWPeter D. Williams
- Vincenzo SummaVSVincenzo Summa
- 1 May 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (10) , 2748-2752
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- DPC-083Drugs of the Future, 2002
- The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistanceJournal of Molecular Biology, 2001
- Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptaseDrug Resistance Updates, 1999
- Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infectionIl Farmaco, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.Proceedings of the National Academy of Sciences, 1994
- Synthesis of 4-keto-1H,4,5-dihydro-1,2,5-benzotriazepines and their chemical behaviourTetrahedron, 1968